lhrtimes.com
AOP Orphan Pharmaceuticals AG to acquire Selisistat - The Lahore Times
A clinical stage drug candidate for the treatment of Huntington’s disease (HD) WIEN: AOP Orphan Pharmaceuticals AG announced today that it has acquired Selisistat,...